United Kingdom, Feb. 19 -- United Kingdom based Fresenius Medical Care (UK) Limited has secured contract from NHS Blood and Transplant for Support of existing Low Density Lipid (LDL) Removal Apheresis Systems. The value of the contract is worth 337798.08 GBP.
Published by HT Digital Content Services with permission from Pivotal Sources....